Lane Labs Must Discontinue SkinAnswer Cancer Claims Under Injunction
This article was originally published in The Rose Sheet
Executive Summary
The seven-year struggle between federal regulators and dietary supplement marketer Lane Labs-USA has formally concluded with a permanent injunction issued in Newark, N.J. federal court July 13
You may also be interested in...
Lane Labs
Dietary supplement firm has discontinued manufacturing skin cream SkinAnswer and two nutritional supplements, Benefin and MGN-3, the company announces, after a permanent injunction was issued July 13 barring the firm from selling the products unless approved by FDA. "We are very disappointed and will pursue an appeal," the company says in a statement. Lane Labs argues the products represent a breakthrough in the natural health industry, but court rules that the items, marketed as cancer therapies, are unapproved new drugs (1"The Rose Sheet" July 19, 2004, p. 7)...
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program